Adamas Pharmaceuticals Inc 3 SEC Filings

Filed On	Filing
24 Nov 2020	Form 3: Papapetropoulos Spyridon, Director Holds 0 shares of Common Stock
01 Sep 2020	Form 3: Richo Anna, Director Holds 10,000 shares of Common Stock
17 Sep 2019	Form 3: McFarlane Neil F., Chief Executive Officer Holds 0 shares of No securities beneficially owned.
04 Jun 2019	Form 3: Shreedhar Vijay, Chief Commercial Officer Holds 0 shares of No securities beneficially owned.
11 Oct 2017	Form 3: Dier Mardi, Director Holds 0 shares of No securities beneficially owned
22 Sep 2017	Form 3: Prentiss Christopher B, Chief Accounting Officer Holds 9,905 shares of Common Stock
06 Jul 2017	Form 3: Merriweather Alfred G, Chief Financial Officer Holds 0 shares of No securities benefically owned
05 May 2017	Form 3: King Richard, Chief Operating Officer Holds 0 shares of No Securities Are Beneficially Owned
22 Sep 2016	Form 3: Bigham Michael, Director Holds 0 shares of No securities beneficially owned
08 Aug 2016	Form 3: Great Point Partners Llc, 10% owner and 2 others Holds 2,601,351 shares of Common Stock
14 Apr 2016	Form 3: Rhodes Jennifer J, General Counsel Holds 0 shares of No securities beneficially owned
09 Jun 2015	Form 3: Patni Rajiv, Chief Medical Officer Holds 0 shares of No securities beneficially owned
03 Dec 2014	Form 3: Shin Grace, General Counsel Holds 0 shares of No securities beneficially owned
29 Aug 2014	Form 3: Dawson William J, Chief Financial Officer
15 Apr 2014	Form 3: aeris Capital Equity Investments, L.p., 10% owner Holds 1,067,532 shares of Common Stock
10 Apr 2014	Form 3: Coffee Michael Denis, Senior VP, Strategy & Planning
09 Apr 2014	Form 3: Mdv Ix Lp, 10% owner and 5 others Holds 2,742,702 shares of Common Stock
09 Apr 2014	Form 3: Mahoney David L, Director Holds 10,674 shares of Common Stock
09 Apr 2014	Form 3: Went Gregory T, Director Holds 6,666 shares of Common Stock
09 Apr 2014	Form 3: Dag Ventures Management III, Llc, 10% owner and 5 others Holds 812,390 shares of Common Stock

Comments